Company Overview and News

12
Gulfport Energy Corporation Provides Second Quarter 2018 Production and Pricing and Schedules Second Quarter 2018 Financial and Operational Results Conference Call

2018-07-16 globenewswire
OKLAHOMA CITY, July 16, 2018 (GLOBE NEWSWIRE) -- Gulfport Energy Corporation (NASDAQ:GPOR) (“Gulfport” or the “Company”) today provided an update for the quarter and six-months ended June 30, 2018. Key information includes the following:
TUSK GPOR

0
GPOR / Gulfport Energy Corp. FORM 8-K (Current Report)

2018-07-13 sec.gov
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
GPOR

12
Mammoth Extends Contract with Gulfport Energy for Pressure Pumping Services

2018-07-12 globenewswire
OKLAHOMA CITY, July 12, 2018 (GLOBE NEWSWIRE) -- Mammoth Energy Services, Inc. (“Mammoth”) (NASDAQ:TUSK) today announced that its wholly owned subsidiary, Stingray Pressure Pumping, LLC (“Stingray”), and Gulfport Energy Corporation (“Gulfport”) (NASDAQ:GPOR) have extended the term of their existing contract under which Stingray provides pressure pumping (“frac”) services to Gulfport to December 31, 2021 - an additional 39 months beyond the original September 30, 2018 termination date.
TUSK GPOR

0
GPOR / Gulfport Energy Corp. / BlackRock Inc. - null (Passive Investment)

2018-07-10 sec.gov
us4026353049_070518.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 11) GULFPORT ENERGY CORPORATION -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 402635304 -------------------------------------------------------- (CUSIP Number) June 30, 2018 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this
GPOR

0
GPOR / Gulfport Energy Corp. / BlackRock Inc. - null (Passive Investment)

2018-07-10 sec.gov
us4026353049_070518.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 11) GULFPORT ENERGY CORPORATION -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 402635304 -------------------------------------------------------- (CUSIP Number) June 30, 2018 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this
GPOR

41
EIA Reports Above-Average Natural Gas Build, Price Falls

2018-07-09 zacks
The Weekly Natural Gas Storage Report – brought out by the Energy Information Administration (EIA) every Thursday since 2002 – includes updates on natural gas market prices, the latest storage level estimates, recent weather data and other market activities or events.
ECR CKRGZ CQP LNG CHKVP CRK COG CHKDH CHKVZ CHKDG CHKWZ CHKDJ CHKDP CHK CHK.WI GPOR CHK.PRD

9
U.S. Oil Executive Pay Increasingly Tied To Investor Returns

2018-07-03 oilprice
Tsvetana is a writer for the U.S.-based Divergente LLC consulting firm with over a decade of experience writing for news outlets such as iNVEZZ and…
HES.PRA APC HES GPOR LPI DVN NFX OXY AEUA EOG

8
Gulfport Energy: Special Situation Conviction Strong Buy

2018-06-26 seekingalpha
We will look into several special recent events that will significantly impact Gulfport's second quarter results.
EQM EQT GPOR

21
4 Reasons These High-Yield, Hyper Growth Income Stocks Could Make You Rich

2018-06-25 seekingalpha
Thanks to a perfect storm of negative (but temporary) factors, MLPs have spent almost four years in a bear market.
ETP.PRC RMP WGL RGCO RICE NEE.PRI NEE.PRJ EQM ETP EQT NEE.PRC GPOR EQGP NEE.PRQ NEE.PRR ED NEE

2
Gulfport Energy Corporation Provides Operational Update

2018-06-19 globenewswire
OKLAHOMA CITY, June 19, 2018 (GLOBE NEWSWIRE) -- Gulfport Energy Corporation (NASDAQ:GPOR) (“Gulfport” or the “Company”) today provided an operational update. Key information includes the following:
TUSK GPOR

77
Why Are Natural Gas Prices Struggling?

2018-06-06 marketrealist
On June 5, natural gas July futures fell 1.4% and settled at $2.89 per MMBtu (million British thermal units). On the same day, Southwestern Energy (SWN) and Gulfport Energy (GPOR) fell 1.9% and 1%, respectively. In contrast, Chesapeake Energy (CHK) didn’t change. These three stocks were the underperformers on our list of natural gas–weighted stocks.
CKRGZ CHKDJ CHKDP CHKVP CHK.WI CHK GPOR CHK.PRD CHKDH CHKVZ CHKDG CHKWZ

92
Rising Inventories Might Help Natural Gas Bulls

2018-06-06 marketrealist
In the week ending May 25, natural gas inventories rose by 96 Bcf (billion cubic feet) to 1,725 Bcf—based on the EIA’s (U.S. Energy Information Administration) data announced on May 31. The increase was 7 Bcf less than what a survey by S&P Global Platts expected. On May 31, natural gas July futures rose 2.3%.
CKRGZ FENY CHKVP CHKDH CHKVZ AR CHKDG CHKWZ CHKDJ CHKDP CHK.WI CHK GPOR CHK.PRD

92
Are Natural Gas Traders Concerned about Rising Production?

2018-06-06 marketrealist
On June 5, natural gas July futures closed at a premium of ~$0.24 to July 2019 futures. The difference is called the “futures spread.” On May 29, the futures spread was at a premium of ~$0.25. On May 29–June 5, natural gas July futures fell 0.4%.
CKRGZ CHKVP CHKDH CHKVZ AR CHKDG CHKWZ CHKDJ CHKDP CHK.WI CHK GPOR CHK.PRD

5
GPOR / Gulfport Energy Corp. 8-K (Current Report)

2018-05-31 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
GPOR

126
Four Reasons Why Natural Gas Prices Could Touch $3 Shortly

2018-05-30 zacks
Over the past few weeks, natural gas prices have risen to levels not seen in almost four months, reflecting a steady, albeit slow, ascent, after being range bound since late January. A confluence of factors could fuel the commodity's march to the psychologically important $3 level this summer.
ECR WFCNP UPL CHKVP CRK WFC.PRL WFC.PRJ CHKDH CHKVZ AR CHKDG WFC.PRT CHKDJ WFC.PRR WFC.PRQ CHKDP WFC.PRP WFC.PRO WFC.PRN GPOR WFC.PRY CHK.PRD WFC.PRX WFC.PRW WFC.PRV WFC WFC.WS CKRGZ CHKWZ CHK CHK.WI UPLMQ

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to GPOR / Gulfport Energy Corp. on message board site Silicon Investor.

LPTI: LONGPORT, INC.
CUSIP: 402635304